September 02, 2013
Gastar Exploration and 12 Stocks Making Deal Buzz This Week
AstraZeneca said Monday that its global biologics research and development unit, MedImmune, will purchase privately held biologics firm Amplimmune, which is centered on developing novel therapeutics in cancer immunology.